METHOD FOR INHIBITING PLISS LYMPHOSARCOMA GROWTH EXPERIMENTALLY Russian patent published in 2015 - IPC G09B23/28 B82B1/00 

FIELD: medicine.

SUBSTANCE: from the 6^th day following Pliss lymphosarcoma transplantation, a ferric nanoparticle suspension concentrated 1 mg/ml in normal saline is administered eight times intraperitoneally or locally into the tumour in male rats. The administration is performed on the 6^th, 7^th, 9^th, 10^th, 14^th, 15^th, 16^th and 17^th days in a single dose of 1.25 mg/kg of the animal's weight.

EFFECT: method enables achieving the anticancer action of the nanoparticles having low toxic body exposure.

2 tbl